Utilizing network pharmacology to explore the underlying mechanism of Qiangzhi decoction in treating Tourette’s syndrome | Zendy

ChengDi Dong | Zendy; Hongshuo Shi | Zendy; Qian Chu | Zendy; Yukun Li | Zendy; Huishan Shi | Zendy; Anran Song | Zendy; Zhaojun Yan | Zendy

Open Access

Utilizing network pharmacology to explore the underlying mechanism of Qiangzhi decoction in treating Tourette’s syndrome

Author(s) -

ChengDi Dong,

Hongshuo Shi,

Qian Chu,

Yukun Li,

Huishan Shi,

Anran Song,

Zhaojun Yan

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-2158

Subject(s) - kegg , tourette syndrome , medicine , systems pharmacology , decoction , traditional chinese medicine , mechanism (biology) , computational biology , pharmacology , dopamine , traditional medicine , gene , biology , psychiatry , genetics , alternative medicine , gene ontology , epistemology , pathology , philosophy , gene expression , drug

Tourette's syndrome (TS) is a neurodevelopmental condition characterized by multiple motor and vocal tics. Qiangzhi decoction (QD), a well-known herbal decoction, has been used in treating TS in China for decades. We have found relevance between the indications of QD and the classic symptoms of TS. The pharmacological mechanisms of QD in treating TS are still unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research